Legal Opinion
Bayer Pharma AG v. Watson Laboratories, Inc.
District Court, D. Delaware
Decided July 18, 2016No. Civil Action No. 12-1726-LPSPublished
1Opinion of the Court
FILED UNDER SEAL
MEMORANDUM OPINION
STARK, United States District Judge:
Bayer Pharma AG, Bayer Intellectual Property GmbH, and Bayer Healthcare Pharmaceuticals Inc. (collectively, “Bayer” or “Plaintiffs”) allege that Watson Laboratories, Inc. (“Watson” or “Defendant”) infringes United States Patent No. 8,071,577 (“the ’577 patent” or “the patent-in-suit”). (D.I. 1) The ’577 patent relates to a multi-phasic regimen and method for oral contraception containing estradiol valerate (“EV”) and dienogest (“DNG”). (D.I. 1-1) EV and DNG are the active ingredients of Bayer’s Natazia® product. (D.I. 1 ¶…
2Cases cited23 opinions
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Stratoflex, Inc. v. Aeroquip CorporationCourt of Appeals for the Federal Circuit · 1983
- Hewlett-Packard Company, Plaintiff/cross-Appellant v. Bausch & Lomb IncorporatedCourt of Appeals for the Federal Circuit · 1990
- Eurand, Inc. v. Mylan Pharmaceuticals Inc.Court of Appeals for the Federal Circuit · 2012
18 more not listed; retrieve them via the Exa API.